With inflation trends, interest rates and energy prices all pulling markets in different directions, reliable cash generation has become a key focus for many investors. The Undervalued Stocks Based On Cash Flows screener targets companies where projected cash flows, as assessed by SWS DCF valuation, suggest a gap between current share price and estimated fair value. That can be useful if you are trying to put capital into businesses where cash flows matter more than short term sentiment. In this article, three stocks from this screener are highlighted to show how investors might think about such opportunities today.

Merck (MRK)

Overview: Merck is a global healthcare company that develops and sells human medicines, vaccines and treatments across cancer, infectious diseases and other conditions, alongside a large animal health business serving livestock and pets.

Operations: Merck generates about US$58.9b from pharmaceuticals, US$6.6b from Animal Health and US$0.4b from other revenue, with the United States contributing US$37.2b of sales and Europe, Middle East and Africa a further US$15.0b.

Market Cap: US$314.9b

Merck stands out on the cash flow screener because it pairs a large oncology franchise and expanding pipeline with an SWS DCF valuation that suggests the stock trades at a discount to estimated fair value, even with a P/E that looks high next to peers. The company is working to offset future pressure from the KEYTRUDA patent cliff through more than 20 potential new growth drivers, including recent approvals like Lipfendra and IDVYNSO and new combinations for KEYTRUDA and Padcev. At the same time, investors need to weigh risks such as high debt, one off losses and GARDASIL softness in China, as well as pricing and tariff pressures, to decide whether the pipeline and new launches adequately compensate for these headwinds.

Merck’s high P/E and discount on the cash flow screener suggest that the market may be mispricing its oncology engine and patent risks. It is worth reading the DCF valuation analysis for Merck to see what the numbers might be signaling next.

Rocket Lab (RKLB)

Overview: Rocket Lab is a Long Beach based space company that designs and launches small and medium class rockets, builds satellites and spacecraft components, and provides on orbit management services for commercial, government, and aerospace customers around the world.

Operations: Rocket Lab generates about US$452.5m from Space Systems and US$227.1m from Launch Services.

Market Cap: US$40.4b

Rocket Lab catches the eye on a cash flow screener because it is trying to become a full service space platform, combining its Electron launch business and growing Space Systems segment with the planned Neutron rocket and a pending US$8b Iridium acquisition that would add a global satellite network and millions of subscribers. Forecasts point to fast revenue and earnings growth, but the company is still loss making, relies on external funding and has seen shareholder dilution, insider selling and a highly volatile share price. If Neutron and the Iridium deal work as intended, Rocket Lab could shift from consuming capital to funding its own expansion. However, setbacks in either area would put that vision under real pressure.

Rocket Lab’s push to turn launches and space systems into a self funding platform is only half the story; the real tension sits inside the analyst forecasts for Rocket Lab that could reveal whether dilution and volatility are just the prelude

Energy Fuels (TSX:EFR)

Overview: Energy Fuels is a Lakewood based producer focused on uranium, rare earth elements and heavy mineral sands, supplying materials used in nuclear fuel, magnets and other advanced industrial applications across a vertically integrated platform in the United States and abroad.

Operations: Energy Fuels generates about US$84.6m in revenue from its Uranium segment, with a small segment adjustment of US$0.3m.

Market Cap: CA$4.0b

Energy Fuels stands out on a cash flow screener because it is trying to build a rare combination of uranium production, rare earth processing and magnet manufacturing. This strategy is backed by a debt free balance sheet and a conditional US$725m U.S. government loan that supports mill expansion and a new U.S. rare earths facility. The pending US$1.9b VAC acquisition would extend that chain from mines through to finished magnets. Forecast revenue and earnings growth, together with a DCF estimate that sits well above the current share price, indicate potential upside if the plan works. The flip side is real execution and funding risk, ongoing losses, and a high valuation on current sales, which means investors need to judge whether the integrated critical minerals story justifies the pressure points that come with it.

Energy Fuels’ push to link uranium, rare earths and magnets, backed by a debt free balance sheet and that US$725m loan, raises big questions about what current pricing really reflects. The analysis report for Energy Fuels could show where the story might surprise next.

The three stocks in this article are just a sample of what the cash flow opportunity set looks like. The full Undervalued Stocks Based On Cash Flows screener surfaces 742 more companies where projected cash flows and current pricing tell equally compelling stories through the Undervalued Stocks Based On Cash Flows screener. Use Simply Wall St to identify, analyze and filter for the specific catalysts, balance sheet strength and cash flow narratives that matter most, so you can focus on the highest conviction ideas for your watchlist.

Take Control of Your Investment Journey

If Energy Fuels or any of these companies have caught your attention, register for FREE with Simply Wall St and add your companies to a Watchlist to monitor the share price against the fair value and track any new developments as they happen. Once you've made your move, manage your holdings with our Portfolio Command Center that filters out the noise to deliver only the most critical, actionable updates. Throughout your journey, our Community allows you to filter the best ideas from thousands of investor perspectives. By uncovering hidden catalysts and risks early, you'll accelerate your decision-making and stay one step ahead of the market.

Seeking Fresh Alternatives Before Others?

Some of the most interesting stocks can move from quiet to breakout while investors are still watching yesterday’s winners. Scan these fresh ideas before the crowd catches on and act now.

• Spot companies quietly building momentum in niche sectors by running the 20 high quality undiscovered gems that filters for quality businesses still flying under most investors’ radar.
• Target resilient cash generators that aim to ride out shocks with the 82 resilient stocks with low risk scores, which focuses on stocks carrying sturdier balance sheets and lower risk scores while it still matters.
• Consider the growth of companies powering modern AI infrastructure through the 54 AI infrastructure stocks and pinpoint suppliers that could benefit if demand keeps building.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.